Results 201 to 210 of about 92,090 (322)
ABSTRACT Gastrointestinal (GI) symptoms are common in CHARGE syndrome, but their frequency and characteristics remain poorly documented due to the complex nature of CHARGE syndrome. This study aimed to determine the prevalence of GI issues in CHARGE syndrome and their impact on quality of life (QoL).
Annie Kakamousias, Kim Blake
wiley +1 more source
Teprotumumab and sensorineural hearing loss: a propensity score-matched retrospective cohort study. [PDF]
Barnett MJL +5 more
europepmc +1 more source
ABSTRACT Keratosis–ichthyosis–deafness (KID) syndrome is a rare autosomal dominant ectodermal disease caused by mutations in the GJB2 gene, which encodes the gap junction protein Connexin 26 (Cx26) located on Chr. 13q12.11. This study presents the first mortality analysis associated with KID syndrome, focusing on a case report of a Latin American ...
Leslie Patrón‐Romero +17 more
wiley +1 more source
FITM2-Related Siddiqi Syndrome in Two Iranian Siblings. [PDF]
Ahmadi R +3 more
europepmc +1 more source
Objective Autophagy is a fundamental biological pathway with vital roles in intracellular homeostasis. During autophagy, defective cargoes including mitochondria are targeted to lysosomes for clearance and recycling. Recessive truncating variants in the autophagy gene EPG5 have been associated with Vici syndrome, a severe early‐onset neurodevelopmental
Hormos Salimi Dafsari +140 more
wiley +1 more source
Optical coherence tomography angiography findings in patients with sudden sensorineural hearing loss. [PDF]
Kim J +5 more
europepmc +1 more source
Familial Progressive Sensorineural Deafness Is Mainly Due to the mtDNA A1555G Mutation and Is Enhanced by Treatment with Aminoglycosides [PDF]
Xavier Estivill +10 more
openalex +1 more source
Ototoxicity in Cancer Therapies
Oral Diseases, EarlyView.
Sady Selaimen da Costa +2 more
wiley +1 more source
ABSTRACT Liver transplantation (LTx) has become, over the years, an increasingly used therapeutic option in patients with inherited metabolic diseases (IMD). Initially performed for Tyrosinemia Type I and ornithine transcarbamylase deficiency, it now accounts as the second indication for pediatric transplants worldwide. The use of LTx has been extended
Andrea Pietrobattista +3 more
wiley +1 more source

